Search

everythinglearnresearchcommunity

for

Search:↓

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Androgen receptors help prostate cancer cells grow and resist drugs.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Skin reactions from cancer treatments might predict how well the treatments work.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Applying a specific inhibitor lightens skin and hair color.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The rash resolved after stopping ponatinib.